- Home
- LDI vs STXS Comparison
LDI vs STXS Comparison
Compare LDI & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LDI
- STXS
- Stock Information
- Founded
- LDI 2010
- STXS 1990
- Country
- LDI United States
- STXS United States
- Employees
- LDI N/A
- STXS N/A
- Industry
- LDI Finance: Consumer Services
- STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- LDI Finance
- STXS Health Care
- Exchange
- LDI Nasdaq
- STXS Nasdaq
- Market Cap
- LDI 221.2M
- STXS 261.1M
- IPO Year
- LDI 2021
- STXS 2004
- Fundamental
- Price
- LDI $3.74
- STXS $2.89
- Analyst Decision
- LDI Sell
- STXS
- Analyst Count
- LDI 3
- STXS 0
- Target Price
- LDI $2.30
- STXS N/A
- AVG Volume (30 Days)
- LDI 4.0M
- STXS 551.6K
- Earning Date
- LDI 11-04-2025
- STXS 08-07-2025
- Dividend Yield
- LDI N/A
- STXS N/A
- EPS Growth
- LDI N/A
- STXS N/A
- EPS
- LDI N/A
- STXS N/A
- Revenue
- LDI $1,124,074,000.00
- STXS $31,806,000.00
- Revenue This Year
- LDI $21.95
- STXS $30.92
- Revenue Next Year
- LDI $15.72
- STXS $43.27
- P/E Ratio
- LDI N/A
- STXS N/A
- Revenue Growth
- LDI 27.06
- STXS 33.94
- 52 Week Low
- LDI $1.01
- STXS $1.54
- 52 Week High
- LDI $3.23
- STXS $3.05
- Technical
- Relative Strength Index (RSI)
- LDI 85.68
- STXS 60.70
- Support Level
- LDI $1.81
- STXS $2.67
- Resistance Level
- LDI $2.16
- STXS $2.92
- Average True Range (ATR)
- LDI 0.23
- STXS 0.13
- MACD
- LDI 0.14
- STXS -0.01
- Stochastic Oscillator
- LDI 90.09
- STXS 59.21
About LDI loanDepot Inc.
loanDepot Inc provides nonbank consumer lending solutions for individuals in the United States. It offers personal, residential home, home refinancing, mortgage and home equity loans. It also provides online mortgage loans for refinancing and home purchases. It serves customers through distribution channels, including consumer direct centres, retail branches, wholesale centres, and consumer finance and servicing centres in the United States. It competes with commercial banks and financial institutions.
About STXS Stereotaxis Inc.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.